<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Bariatric surgery becomes more and more important in the management of the <z:mp ids='MP_0001261'>obese</z:mp> patient with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, especially in case of failure of medical approaches </plain></SENT>
<SENT sid="1" pm="."><plain>Metabolic improvement results not only from <z:hpo ids='HP_0001824'>weight loss</z:hpo> and the subsequent reduction in <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, but also from modifications of digestive hormones (especially incretins) that contribute to promote insulin secretion </plain></SENT>
<SENT sid="2" pm="."><plain>This new paradigm, moving from bariatric surgery to metabolic surgery, opens new perspectives </plain></SENT>
<SENT sid="3" pm="."><plain>The present article briefly describes innovative surgical techniques focusing on <z:chebi fb="32" ids="24621">endocrine</z:chebi> and metabolic improvement rather than on <z:hpo ids='HP_0001824'>weight loss</z:hpo>, the preliminary results of metabolic surgery in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and a body mass index &lt;35 kg/m2 and, finally, some data regarding the surgical management of <z:mp ids='MP_0001261'>obese</z:mp> patients with <z:mp ids='MP_0002056'>type I diabetes</z:mp> not well treated with classical medical means </plain></SENT>
</text></document>